0001073397-20-000001.txt : 20200601 0001073397-20-000001.hdr.sgml : 20200601 20200601165146 ACCESSION NUMBER: 0001073397-20-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200528 FILED AS OF DATE: 20200601 DATE AS OF CHANGE: 20200601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LOPEZ GEORGE A CENTRAL INDEX KEY: 0001073397 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34634 FILM NUMBER: 20934007 MAIL ADDRESS: STREET 1: C/O ICU MEDICAL STREET 2: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-05-28 0 0000883984 ICU MEDICAL INC/DE ICUI 0001073397 LOPEZ GEORGE A 951 CALLE AMANECER SAN CLEMENTE CA 92673 1 0 1 0 Common Stock 2020-05-28 4 X 0 6438 43.62 A 346202 D Common Stock 2020-05-28 4 S 0 16548 197.3739 D 329654 D Common Stock 2020-05-28 4 S 0 3 198.09 D 329651 D Common Stock 2020-05-28 4 X 0 10113 46.53 A 339764 D Common Stock 986843 I by Partnership Non-Qualified Stock Option (right to buy) 43.62 2020-05-28 4 X 0 6438 43.62 D 2021-07-20 Common Stock 6438 0 D Non-Qualified Stock Option (right to buy) 46.53 2020-05-28 4 X 0 10113 46.53 D 2022-02-01 Common Stock 10113 78744 D The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $197.00 to $197.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. All shares sold were sold at the exact price disclosed. Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. By: Paula Darbyshire, Attorney-in-fact For: George A. Lopez, M.D. 2020-06-01